Skip to main content
SpringerLink
Log in

Brentuximab vedotin

Progressive multifocal leukoencephalopathy: 3 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin). Internet Document: 17 Jan 2012. Available from: URL: http://www.fda.gov/drugs/drugsafety/ucm287668.htm - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brentuximab vedotin. React. Wkly. 1385, 12 (2012). https://doi.org/10.2165/00128415-201213850-00038

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213850-00038

Keywords

Search

Navigation